Investing Profile

Josh Bilenker

VC
Photo of Josh Bilenker, Partner at Aisling Capital
Your Intro Paths to Josh Bilenker
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Josh Bilenker on

cb
Current Investing Position
Aisling Capital Partner
Investments On Record
18
Current Fund Size
$280M

Josh Bilenker is on these Sector & Stage Rankings

Josh Bilenker's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
ViewRay
Post Ipo EquityJul 2015$27M
Series UnknownDec 2013$30M
Series UnknownMay 2013$15M
Series CMar 2012$45M
Debt FinancingSep 2011$10M
Series CAug 2010$20M
Series BJan 2008$25M
$170M
LENSAR
Private EquityJan 2015$16M
Series UnknownOct 2013$27M
Debt FinancingOct 2013$60M
Series UnknownMar 2012$24M
$130M
Loxo Oncology
Series BMay 2014$24M
Series AOct 2013$33M
$72M
Co-investors: David Bonita (OrbiMed), Martin Alexander Gershon (Endeavor Venture Funds), Dov Goldstein (Aisling Capital), James Barrett
T2 Biosystems
Series EMar 2013$40M
Series DAug 2011$23M
$96M
Co-investors: Harry Wilcox (Flagship Pioneering), Alan Crane (Polaris Partners), Michael Greeley (Flare Capital Partners), Stacy Feld (Johnson & Johnson Innovation)
Aragon Pharmaceuticals
Series DOct 2012$50M
Series BApr 2010$22M
$80M
Co-investors: Carl Gordon (OrbiMed), Brett Zbar (General Atlantic), Peter Svennilson (The Column Group)
Roka Bioscience
Series DJan 2012$48M
$68M
Co-investors: Jonathan Silverstein (OrbiMed), James Barrett